Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas

British Journal of Surgery

Volumn 101, Issue 2, 2014, Pages 79-88

  Ebata, T ^a   Kosuge, T ^b   Hirano, S ^f   Unno, M ^g   Yamamoto, M ^c   Miyazaki, M ^h   Kokudo, N ^d   Miyagawa, S ⁱ   Takada, T ^e   Nagino, M ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891312426     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9379     Document Type: Article

References (30)

1. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al., Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-473.
2. Ebata T, Kamiya J, Nishio H, Nagasaka T, Nimura Y, Nagino M,. The concept of perihilar cholangiocarcinoma is valid. Br J Surg 2009; 96: 926-934.
3. Sobin LH, Gospodarowicz MK, Wittekind C, (eds). UICC TNM Classification of Malignant Tumours (7th edn). Wiley-Blackwell: New York, 2009.
4. Bismuth H, Nakache R, Diamond T,. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-38.
5. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al., Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507-517.
6. Japanese Society of Biliary Surgery. General Rules for Surgical and Pathological Studies on Cancer of Biliary Tract (in Japanese) (3rd edn). Kanehara: Tokyo, 1993.
7. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S,. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990; 14: 535-543.
8. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M,. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230: 663-671.
9. Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, et al., Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238: 73-83.
10. Nagino M, Kamiya J, Arai T, Nishio H, Ebata T, Nimura Y,. 'Anatomic' right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann Surg 2006; 243: 28-32.
11. Esaki M, Shimada K, Nara S, Kishi Y, Sakamoto Y, Kosuge T, et al., Left hepatic trisectionectomy for advanced perihilar cholangiocarcinoma. Br J Surg 2013; 100: 801-807.
12. Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y,. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 2003; 238: 720-727.
13. Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, et al., Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 2007; 141: 581-588.
14. Nagino M, Nimura Y, Nishio H, Ebata T, Igami T, Matsushita M, et al., Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg 2010; 252: 115-123.
15. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al., Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230: 808-818.
16. Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K,. No-touch resection of hilar malignancies with right hepatectomy and routine portal reconstruction. J Hepatobiliary Pancreat Surg 2009; 16: 502-507.
17. Miyagawa S, Makuuchi M, Kawasaki S, Hayashi K, Harada H, Kitamura H, et al., Outcome of major hepatectomy with pancreatoduodenectomy for advanced biliary malignancies. World J Surg 1996; 20: 77-80.
18. Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, et al., Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg 2012; 256: 297-305.
19. Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K,. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 2005; 103: 1210-1216.
20. Regimbeau JM, Fuks D, Le Treut YP, Bachellier P, Belghiti J, Boudjema K, et al., Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group. J Gastrointest Surg 2011; 15: 480-488.
21. Nuzzo G, Giuliante F, Ardito F, Giovannini I, Aldrighetti L, Belli G, et al., Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 2012; 147: 26-34.
22. de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, et al., The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer 2012; 118: 4737-4747.
23. Bosman FT, Carneiro F, Hruban RH, Theise ND,. WHO Classification of Tumours of the Digestive System (4th edn). International Agency for Research on Cancer: Lyon, 2010.
24. Deoliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, et al., New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 2011; 53: 1363-1371.
25. DeOliveira ML, Clavien PA,. A common language to describe perihilar cholangiocarcinoma. Br J Surg 2012; 99: 885-886.
26. Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M,. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer 1977; 39: 232-246.
27. Yamanaka N, Okamoto E, Ando T, Oriyama T, Fujimoto J, Furukawa K, et al., Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995; 76: 2449-2456.
28. Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, et al., Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol 2007; 31: 1059-1067.
29. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM,. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006; 98: 873-875.
30. Horgan AM, Amir E, Walter T, Knox JJ,. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol 2012; 30: 1934-1940.